Radafaxine Hydrochloride

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameRadafaxine Hydrochloride
Drug Alias Name瑞德法辛Radafaxine雷达法辛Bupropion metaboliteRadafaxina +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsAdrenergic receptors antagonistsNicotinic acetylcholine receptor alpha4/beta2/alpha5 antagonists
TargetsDopamine transporterAdrenergic receptorsNicotinic acetylcholine receptor alpha4/beta2/alpha5
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksKEGG